124 related articles for article (PubMed ID: 23766477)
1. Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions.
McAllister IL; Vijayasekaran S; Yu DY
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4910-8. PubMed ID: 23766477
[TBL] [Abstract][Full Text] [Related]
2. A study of retinal penetration of intravitreal tenecteplase in pigs.
Kwan AS; Vijayasekaran S; McAllister IL; Yu PK; Yu DY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2662-7. PubMed ID: 16723484
[TBL] [Abstract][Full Text] [Related]
3. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion.
Mahmoud TH; Peng YW; Proia AD; Davidson M; Deramo VA; Fekrat S
Br J Ophthalmol; 2006 Jul; 90(7):911-5. PubMed ID: 16540487
[TBL] [Abstract][Full Text] [Related]
4. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
5. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
McAllister IL; Vijayasekaran S; Chen SD; Yu DY
Am J Ophthalmol; 2009 May; 147(5):838-46, 846.e1-2. PubMed ID: 19211093
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.
Vijayasekaran S; McAllister IL; Morgan WH; Mendis KR; McMenamin PG; Cringle SJ; Yu DY
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):215-22. PubMed ID: 20652816
[TBL] [Abstract][Full Text] [Related]
7. Impact of intravitreal injection of tissue plasminogen activator on full-field electroretinogram in patients with macular oedema secondary to retinal vein occlusion.
Tagami M; Kusuhara S; Imai H; Honda S; Tsukahara Y; Negi A
Ophthalmologica; 2011; 226(2):81-6. PubMed ID: 21625191
[TBL] [Abstract][Full Text] [Related]
8. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
[TBL] [Abstract][Full Text] [Related]
9. Retinal Penetration of Intravitreally Injected Tissue Plasminogen Activator: A Rat Model Study.
Tal K; Dotan A; Nisgav Y; Dachbash M; Gal-Or O; Ehrlich R; Gaton DD; Weinberger D; Livnat T
Ophthalmic Res; 2018; 59(4):235-240. PubMed ID: 28728144
[TBL] [Abstract][Full Text] [Related]
10. Experimental endoscopic endovascular cannulation: a novel approach to thrombolysis in retinal vessel occlusion.
Hattenbach LO; Puchta J; Hilgenberg I
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):42-6. PubMed ID: 22131392
[TBL] [Abstract][Full Text] [Related]
11. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.
Pournaras CJ; Petropoulos IK; Pournaras JA; Stangos AN; Gilodi N; Rungger-Brändle E
Retina; 2012 Sep; 32(8):1566-73. PubMed ID: 22466460
[TBL] [Abstract][Full Text] [Related]
12. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
Kamei M; Misono K; Lewis H
Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
[TBL] [Abstract][Full Text] [Related]
13. Retinal proteome changes following experimental branch retinal vein occlusion and intervention with ranibizumab.
Cehofski LJ; Kruse A; Bøgsted M; Magnusdottir SO; Stensballe A; Honoré B; Vorum H
Exp Eye Res; 2016 Nov; 152():49-56. PubMed ID: 27619476
[TBL] [Abstract][Full Text] [Related]
14. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
[TBL] [Abstract][Full Text] [Related]
16. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
Retina; 2009; 29(7):932-40. PubMed ID: 19584651
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal functional plasminogen in eyes with branch retinal vein occlusion.
Bertelmann T; Sekundo W; Strodthoff S; Witteborn MC; Stief T; Irle S; Nguyen N; Koss MJ; Mennel S
Ophthalmic Res; 2014; 52(2):74-80. PubMed ID: 25059575
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
Lahey JM; Fong DS; Kearney J
Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
[TBL] [Abstract][Full Text] [Related]
19. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
Gabrail N; Sandler E; Charu V; Anas N; Lim E; Blaney M; Ashby M; Gillespie BS; Begelman SM
J Vasc Interv Radiol; 2010 Dec; 21(12):1852-8. PubMed ID: 21111365
[TBL] [Abstract][Full Text] [Related]
20. Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model.
Yamamoto T; Kamei M; Kunavisarut P; Suzuki M; Tano Y
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):509-14. PubMed ID: 17960414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
